Hypercoagulability state is common in patients with coronavirus disease 2019 (COVID-19), especially those requiring intensive care. Indeed, anticoagulation therapy is recommended for all hospitalized COVID-19-patients. Despite well-conducted thromboprophylaxis, so many patients have developed these life-threatening complications. However, these thrombotic events are not known to occur in asymptomatic COVID-19 patients or in those recovered from active severe acute respiratory syndrome coronavirus 2 infection. This case series of a bilateral pulmonary embolism that occurred in patients recovered from asymptomatic COVID-19 highlights the questions about extending thromboprophylaxis in ambulatory patients with COVID-19.
【저자키워드】 post-COVID-19, Asymptomatic disease, Thromboprophylaxis, bilateral pulmonary embolism, 【초록키워드】 COVID-19, coronavirus disease, coronavirus, therapy, Hospitalized, anticoagulation, intensive care, Patient, complications, Asymptomatic COVID-19, acute respiratory syndrome, life-threatening, thrombotic event, highlight, occurred, case sery, question, occur, ambulatory patient, with COVID-19, 【제목키워드】 COVID-19, pulmonary, recovered, Embolism, Bilateral,